Brief: Clinical Trial With Remygen Expanded To Evaluate Prevention Of Hypoglycaemia
24/08/2020 13:17
Aug 24 (Reuters) - Diamyd Medical AB DMYDb.ST :
* CLINICAL TRIAL WITH REMYGEN ® IS EXPANDED TO EVALUATE PREVENTION OF HYPOGLYCAEMIA
* SWEDISH MEDICAL PRODUCTS AGENCY APPROVED AMENDMENT TO REGENERATE-1 TO INVESTIGATE
REMYGEN'S
PREVENTIVE EFFECTS ON HYPOGLYCAEMIA (SEVERELY REDUCED BLOOD SUGAR LEVEL) IN INDIVIDUALS WITH
LONG-TERM TYPE 1 DIABETES.
Source text for Eikon: ID:nWkr7qNTTL
Further company coverage: DMYDb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))